Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor
US-2024402163-A1 · Dec 5, 2024 · US
US10078078B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10078078-B2 |
| Application number | US-201615210634-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 14, 2016 |
| Priority date | Apr 18, 2006 |
| Publication date | Sep 18, 2018 |
| Grant date | Sep 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to bead incubating and washing on a droplet actuator. Methods for incubating magnetically responsive beads that are labeled with primary antibody, a sample (i.e., analyte), and secondary reporter antibodies on a magnet, on and off a magnet, and completely off a magnet are provided. Also provided are methods for washing magnetically responsive beads using shape-assisted merging of droplets. Also provided are methods for shape-mediated splitting, transporting, and dispensing of a sample droplet that contains magnetically responsive beads. The apparatuses and methods of the invention provide for rapid time to result and optimum detection of an analyte in an immunoassay.
Opening claim text (preview).
The invention claimed is: 1. A method of incubating droplets having magnetically responsive beads therein, the method comprising: (a) providing a droplet actuator comprising: (i) droplet operations electrodes arranged for conducting droplet operations on a droplet operations surface; and (ii) a magnet positioned relative to the droplet operations surface such that a droplet controlled by one or more of the droplet operations electrodes may be positioned within or away from a first region of the magnet's magnetic field capable of substantially attracting magnetically responsive beads in the droplet; (b) positioning a droplet having magnetically responsive beads therein at a location within the first region of the magnetic field of the magnet to form a concentration of beads in the droplet; (c) transporting the droplet through activation of selected droplet operations electrodes away from the first region of the magnetic field of the magnet to resuspend the magnetically responsive beads in the droplet; (d) operating the droplet operations electrodes to cause the droplet to elongate and then split into two droplets at a location away from the magnet; and (e) operating the droplet operations electrodes to merge the two droplets into a single droplet at a location away from the magnet, whereby the transporting, splitting, and merging comprise an incubation cycle. 2. The method of claim 1 , wherein in step (b) the concentration of magnetically responsive beads occurs at an edge of the droplet adjacent the magnet. 3. The method of claim 1 , wherein the droplet transported has a footprint approximately three times the area of a single droplet operations electrode. 4. The method of claim 1 , wherein the droplet comprises a sample comprising a target substance, and the magnetically responsive beads have an affinity for the target substance. 5. The method of claim 4 , wherein the target substances are at least one of cells, protein, nucleic acid, and an antigen. 6. The method of claim 1 , wherein the transporting, splitting, and merging operations are repeated a plurality of times. 7. The method of claim 1 , wherein the droplet comprises one part magnetically responsive beads and one part sample. 8. The method of claim 1 , wherein the droplet comprises one part magnetically responsive beads and one part secondary reporter antibodies. 9. The method of claim 1 , wherein the incubation cycle is conducted substantially outside of the first region of the magnetic field. 10. The method of claim 1 , wherein the droplet is a sample droplet having a target antigen as a sample therein. 11. The method of claim 1 , wherein the droplet transported has a footprint approximately two times the area of a single droplet operations electrode. 12. The method of claim 4 , wherein the target substance is a cytokine.
Volumetric liquid transfer · CPC title
Dilution · CPC title
including sample preparation · CPC title
Automated chemical analysis · CPC title
Levitated, suspended drops · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.